Delivery Order 75N95024D00038-75N95024F00001
- Not listed
- Psychogenics Inc., doing business as Psychogenics Inc., has been awarded a $45.9 million delivery order contract by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to provide screening of investigational agents through the Preclinical Screening Platform for Pain. The cost plus fixed fee contract will be performed over a five year period in Paramus, New Jersey. Under the contract, Psychogenics will screen investigational pain treatment agents through...
- Psychogenics Inc. was awarded a $1.8 million cost-plus-fixed-fee delivery order contract by the National Institute of Neurological Disorders and Stroke to support the Preclinical Screening Platform for Pain program. Under this contract, Psychogenics will provide identification and validation of novel pain-related endpoints and animal models of pain, as well as profiling of investigational agents in rodent and non-rodent species excluding non-human primates. This delivery order was issued against...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $462,900.00 contract to The Conjugate Group LLC, a small disadvantaged business, to provide regulatory affairs consultant support services. The contract has a base period of one year beginning September 2023 with two optional one-year extensions. The services are in support of the NIH Blueprint Neurotherapeutics program and the NIH HEAL Pain Therapeutics Development Program, as well as other NINDS...
- <p>The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, awarded a $10,000.00 Firm Fixed Price Purchase Order to David H Presky for BIOLOGICAL THERAPEUTICS CONSULTATION SERVICES. The contract has an ultimate completion date of July 9, 2025. This is an open-market contract award with no set-aside designation. The award was made on July 10, 2024. NINDS is the funding agency for this contract.</p>
- <p>The National Institute of Neurological Disorders and Stroke (NINDS), a civilian federal agency, awarded a $10,000 firm fixed-price purchase order contract to Jeffrey Kennedy for consultation services with pain expertise on the Executive Oversight Committee (EOC) board. The contract has an ultimate completion date of August 27, 2025 and was awarded on August 28, 2024. The contract is not associated with a set-aside program.</p>
- The Department of Health and Human Services' National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $20,446 purchase order to Eurofins Discoverx Corporation of Fremont, California. Under the firm fixed price contract, Eurofins will provide GPCRMAX PANEL services to NIH NINDS from August 2023 through December 2023. As a leading provider of drug discovery services, Eurofins will support NINDS's work to understand, treat, and prevent disorders of the brain...
- This is a $473,586.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS) to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The contract, which does not have a set-aside designation, is part of NINDS's Pharmacology and Toxicology for Therapeutics Program and supports preclinical research activities, including toxicology studies and safety assessments of potential...
- This is a $244,800 contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to RPK Associates, LLC, a small business. The contract is for biological therapeutics product development subject matter expert consulting services to support the development of cell and gene therapy products for NIH drug discovery and development programs, including the NIH Blueprint Neurotherapeutics Network Biologics (BPN-Biologics)...
- This federal contract award, valued at $1,884,275.00, was issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to Pharmalex US Corporation for Biologics Subject Matter Expert (SME) Consulting Services. The contract is a total small business set-aside, with a period of performance through April 14, 2025. The award is in support of NINDS programs such as the Blueprint Neurotherapeutics Network Biologics (BPN-Biologics), the Ultra-Rare Gene Therapy...
- This $509,100 federal contract was awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), to Steven Young Consulting LLC to provide Medicinal Chemistry consultant support services. The contract supports the NIH Blueprint Neurotherapeutics Network drug discovery programs, the Help End Addiction Long-Term (HEAL) initiative to develop non-addictive pain therapies, and other NIH neuroscience drug development efforts....
- 75N95024D00038Indefinite Delivery Contract
- 75N95024D00038-75N95024F00001Delivery Order
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $65,840,279.00 cost-plus-fixed-fee delivery order contract to Psychogenics Inc., a for-profit contract research organization located in Paramus, New Jersey. The contract is for the "Screening of Investigational Agents through the NINDS Preclinical Screening Platform for Pain (PSPP)," which supports the NIH's Helping to End Addiction Long-term (HEAL) initiative. The contract involves comprehensive in-vitro and in-vivo testing of investigational agents to evaluate their efficacy, pharmacokinetics, side effects, and abuse liability across various pain models. The contract is part of a larger $80,000,000.00 Indefinite Delivery Contract (IDV) established by NINDS to support the PSPP program. This contract does not have a set-aside designation.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
NINDS Preclinical Screening Platform for Pain (PSPP) | 75N95024R00054 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Pre-Solicitation 1/3 | 4/2/24, 2:45 PM | |
Award Notice for NINDS Preclinical Screening Platform for Pain (PSPP) | 75N95024D00038 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Award Notice 3/3 | 9/20/24, 5:52 PM | |
PSPP RFP | 75N95024R00054 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 2/3 | 4/30/24, 9:23 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $9.5m | 8/20/25 | |
| Not listed | Not listed | $11.8m | 9/6/24 |